Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat

Journal of the American Society of Nephrology

Volumn 11, Issue 3, 2000, Pages 454-467

  Gobé, Glenda ^a   Zhang, Xiao Ju ^a   Willgoss, Desley A ^a   Schock, Estelle ^a   Hogg, Nicole A ^a   Endre, Zoltán H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; KIDNEY ARTERY STENOSIS; KIDNEY DISTAL TUBULE; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; MALE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT;

EID: 0034050706     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Schumer M, Colombel M, Sawczuk I, Gobé G, Connor J, O'Toole K, Olsson C, Wise G, Buttyan R: Morphological, biochemical and molecular parameters distinguish the mode of cell death following severe ischemia from the cell deaths associated with ischemia-reperfusion injury. Am J Pathol 140: 831-838, 1992
2. Bonventre J: Mechanisms of ischemic acute renal failure. Kidney Int 43: 1160-1178, 1993
3. Nouwen EJ, Verstrepen WA, Buyssens N, Zhu MQ, de Broe ME: Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab Invest 70: 479-493, 1994
4. Basile DP, Liapis H, Hammerman MR: Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. Am J Physiol 272: F640-F647, 1997
5. Racusen L, Fivush B, Li YL, Solez K: Dissociation of tubular cell detachment and tubular cell death in clinical and experimental "acute tubular necrosis." Lab Invest 64: 546-554, 1991
6. Gobé GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis: Role of apoptosis. Lab Invest 56: 273-281, 1987
7. Gobé GC, Axelsen RA, Searle JW: Cellular events in experimental unilateral ischemic renal atrophy, and in regeneration after contralateral nephrectomy. Lab Invest 63: 770-779, 1990
8. Buttyan R, Gobe G: Apoptosis in the mammalian kidney: Incidence, effectors, and molecular control in normal and disease states. In: Advances in Pharmacology, edited by Kaufmann SH, San Diego, Academic Press, 1997, pp 369-381
9. Racusen L: The histopathology of acute renal failure. In: Critical Care Nephrology, edited by Ronco C, Bellomo R, Amsterdam, The Netherlands, Kluwer Academic Publishers, 1998, pp 623-630
10. Lieberthal W, Nigam SK: Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 275: F623-F631, 1998
11. Shanley P, Brezis M, Spokes K, Silva P, Epstein F, Rosen S: Hypoxic injury in the proximal tubule of the isolated perfused rat kidney. Kidney Int 29: 1021-1032, 1986
12. Brezis M, Shanley P, Silva P, Spokes K, Lear S, Epstein FH, Rosen S: Disparate mechanisms for hypoxic injury in different nephron segments: Studies in the isolated perfused rat kidney. J Clin Invest 76: 1796-1806, 1985
13. Endre ZH, Ratcliffe PJ, Tange JD, Ferguson DJ, Radda GK, Leddingham JG: Erythrocytes alter the pattern of renal hypoxic injury: Predominance of proximal tubular injury with moderate hypoxia. Clin Sci 76: 19-29, 1989
14. Vaux D, Cory S, Adams J: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442, 1988
15. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990
16. Oltvai Z, Korsmeyer S: Checkpoints of dueling dimers foil death wishes. Cell 79: 189-192, 1994
17. Yin C, Oltvai Z, Korsmeyer SJ: Heterodimerisation with Bax is required for Bcl-2 to repress cell death. Curr Top Microbiol Immunol 194: 331-338, 1995
18. Oltvai Z, Milliman C, Korsmeyer S: Bcl-2 hetrodimerisation with a conserved homolog Bax that accelerated programmed cell death in vivo. Cell 74: 609-619, 1993
19. Le Brun D, Warnke R, Cleary M: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142: 743-753, 1993
20. Chandler D, el Naggar AK, Brisbay S, Redline RW, McDonnell TJ: Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney. Hum Pathol 25: 789-796, 1994
21. Kamada S, Shimono A, Shinto Y, Tsujimura T, Takahashi T, Noda T, Kitamura Y, Kondoh H, Tsujimoto Y: Bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res 55: 354-359, 1995
22. Sorenson CM, Rogers SA, Korsmeyer SJ, Hammerman MR: Fulminant metanephric apoptosis and abnormal kidney development in bcl-2 deficient mice. Am J Physiol 268: F73-F81, 1995
23. Sorenson C, Padanilam B, Hammerman M: Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse. Am J Physiol 271: F184-F193, 1996
24. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96-99, 1995
25. Boise LH, Gonzalez-Garcia M, Postema C, Ding L, Lindsten T, Turka L, Mao X, Nunez G, Thompson CB: Bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-606, 1993
26. L is the major bcl-x mRNA form expressed during murine development and its product localises to mitochondria. Development 120: 3033-3042, 1994
27. Winyard P, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon RA, Woolf AS: Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 49: 135-146, 1996
28. Hammerman MR, Miller SB: Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 5: 1-11, 1996
29. Hirschberg R: Biologically active peptides in acute renal failure: Recent clinical trials. Nephrol Dial Transplant 12: 1563-1566, 1997
30. Galli G, Fratelli M: Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: Inhibition by L-acetylcarnitine. Exp Cell Res 204: 54-60, 1993
31. Buttke T, Sandstrom P: Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7-10, 1994
32. Linette G, Li Y, Roth K, Korsmeyer S: Cross talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 93: 9545-9552, 1996
33. Taira T, Yoshimura A, Iizuka K, Inui K, Oshiden K, Iwasaki S, Ideura T, Koshikawa S: Expression of epidermal growth factor and its receptor in rabbits with ischemic acute renal failure. Virchows Arch 427: 583-588, 1996
34. Horak E, Hopfer SM, Sunderman FW: Spectrophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem 27: 1180-1185, 1981
35. Westhuyzen J, McGiffin DC, McCarthy J, Fleming SJ: Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 228: 123-132, 1994
36. Ansari B, Coates PJ, Greenstein BD, Hall PA: In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170: 1-8, 1993
37. Gavrieli Y, Sherman Y, Ben-Sasson S: Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J Cell Biol 119: 493-501, 1992
38. Walker NI, Harmon BV, Gobé GC, Kerr JFR: Patterns of cell death. Methods Achiev Exp Pathol 13: 18-54, 1988
39. Kerr JFR, Gobé GC, Winterford C, Harmon BV: Anatomical methods in cell death. In: Methods in Cell Biology edited by Schwartz LM, Osborne BA, San Diego, Academic Press, 1995, pp 1-27
40. Wever PC, Aten J, Rentenaar RJ, Hack CE, Koopman G, Weening JJ, Ten Berge IJM: Apoptotic tubular cell death during acute renal allograft rejection. Clin Nephrol 49: 28-34, 1988
41. Elkind MM: Repair processes in radiation biology. Radiat Res 100: 425-449, 1984
42. Kadkhodaee M, Gobé G, Willgoss D, Endre Z: DNA fragmentation reduced by anti-oxidants following ischemia-reperfusion in the isolated rat kidney. Nephrology 4: 163-175, 1998
43. Nelms BE, Maser RS, MacKay JF, Lagally MG, Petrini JHJ: In situ visualization of DNA double-strand break repair in human fibroblasts. Science 280: 590-592, 1988
44. Witzgall R, Brown D, Schwartz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney: Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-2188, 1994
45. Raff M, Barres B, Burne J, Coles H, Ishizaki Y, Jacobson M: Programmed cell death and the control of cell survival. Philos Trans R Soc Lond 345: 265-268, 1994
46. Rao L, White E: Bcl-2 and the ICE family of apoptotic regulators: Making a connection. Curr Opin Genet Dev 7: 52-58, 1997
47. Zager RA, Fuerstenberg SM, Myerson D, Torok-Storb B: An evaluation of antioxidant effects on recovery from postischemic acute renal failure. J Am Soc Nephrol 4: 1588-1597, 1994
48. Beeri R, Symon Z, Brezis M, Ben Sasson SA, Baehr PH, Rosen S, Zager RA: Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 47: 1806-1810, 1995
49. Grasl-Kraup B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Herrmann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology 21: 1465-1468, 1995
50. O'Connor A, Nishigori C, Yarosh D, Alas L, Kibitel J, Burley L, Cox P, Bucana C, Ullrich S, Kripke M: DNA double strand breaks in epidermal cells cause immune suppression in vivo and cytokine production in vitro. J Immunol 157: 271-278, 1996
51. Hockenbery D, Oltvai Z, Yin X-M, Milliman C, Korsmeyer S: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251, 1993
52. Korsmeyer SJ, Yin X-M, Oltvai Z, Veis-Novack D, Linette G: Reactive oxygen species and the regulation of cell death by the bcl-2 gene family. Biochem Biophys Acta 1271: 63-66, 1995
53. L. Nature 374: 811-813, 1995
54. Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84: 1757-1761, 1989
55. Ong AC, Fine LG: Tubular derived cytokines and human renal disease. Nephrol Dial Transplant 9: 471-473, 1994
56. Nouwen EJ, Verstrepen WA, de Broe ME: Epidermal growth factor in acute renal failure. Renal Failure 16: 49-60, 1994
57. Safirstein R: Gene expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 4: 1387-1395, 1993
58. Walton G, Buttyan R, Olsson C, Hensle T, Sawczuk I: Expression of renal growth factors during experimental hydronephrosis. J Urol 148: 510-517, 1993
59. Andersson G, Jennische E: IGF-1 immunoreactivity is expressed by regenerating renal tubular cells after ischemic injury in the rat. Acta Physiol Scand 132: 453-457, 1988
60. Lin J, Cybulsky AV, Goodyer PR, Fine RN, Kaskel FJ: Insulin-like growth factor-1 enhances epidermal growth factorreceptor activation and renal tubular cell regeneration in postischemic acute renal failure. J Lab Clin Med 125: 724-733, 1995
61. Matejka GL, Jennische E: IGF-1 binding and IGF-1 mRNA expression in the post-ischemic regenerating rat kidney. Kidney Int 42: 1113-1123, 1992
62. Evan A, Henry D, Connors B, Summerlin P, Lee WH: Analysis of insulin-like growth factors IGF-I and -II, type II IGF receptor and IGF-binding protein-2 mRNA and peptide levels in normal and nephrectomized rat kidney. Kidney Int 48: 1517-1529, 1995
63. Basile DP, Rovak JM, Martin DR, Hammerman MR: Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol 270: F500-F509, 1996
64. Border W, Noble N: TGF-β in kidney fibrosis: A target for gene therapy. Kidney Int 51: 1388-1396, 1997
65. Humes HD, Liu S: Cellular and molecular basis of renal repair in acute renal failure. J Lab Clin Med 124: 749-754, 1994